Pfizer Inc. buy BMO Capital Markets
Start price
02.08.23
/
50%
€32.40
Target price
02.08.24
€40.22
Performance (%)
-15.59%
End price
03.08.24
€27.35
Summary
This prediction ended on 03.08.24 with a price of €27.35. The price of Pfizer Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.59%. BMO_Capital_Markets has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. A total of €1.93 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pfizer Inc. | -0.500% | -0.500% | -20.093% |
iShares Core DAX® | 1.308% | 1.167% | 25.330% |
iShares Nasdaq 100 | -0.156% | 1.246% | 27.119% |
iShares Nikkei 225® | 1.270% | 0.293% | 18.646% |
iShares S&P 500 | 0.476% | 1.292% | 27.786% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at BMO Capital Markets from $45.00 to $44.00. They now have an "outperform" rating on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten